Recent studies have shown the occurrence of recurrent FGFR2 fusion events in iCCA patients (16% of patients); FGFR2 fusions are very rare in other primary liver tumors, being virtually absent in HCCs [36]. Here, FGFR2 is linked to liver cancer.